Pallavi Jha, New Delhi: There is good news among the outcry from Corona. The Drugs Regulator of India has approved Virafin of Zydus. This medicine is used in the treatment of corona. The Drugs Controller General of India (DCGI) has approved this drug of Zydus. Zydus claimed that 91.15% of corona victims had RT-PCR test negative in just one day after the use of Virafin.
Virafin injection of Zydus Cadila will be used for adults who have corona and have mild symptoms. The company claims that Virafin helps corona patients recover more quickly and they do not have much problem with corona.
According to the company, if the drug Viraffin is given at the beginning of the Corona virus infection, then the patients will get a lot of help in recovering from the disease and also reduce the discomfort. However, this medicine will be given only after the advice of the doctor and the medicine will be available only in hospitals. The company had tried this drug at 25 centers, with good results.
Earlier, Zydus Cadila sought approval from the Drug Controller General of India for the treatment of Kovid-19 in the drug PegiHep. The company had said that the Pegylated Interferon Alpha 2b or PegiHep drug proved to be effective 91.15 percent. The initial third-stage human trial yielded promising results from the drug. Interim results indicated that timely delivery of the drug may help patients recover more quickly and avoid the complication seen in the developing stages of the disease.
It has been said by the firm company that this drug will prove to be more effective on people above the age of 18 years, in which mild symptoms are found. In a statement issued by the company last week, it was said that if the medicine is given to the patients at the beginning of the disease, then it can help in quick recovery. Also, complications in the advanced stage of the insurer can also be avoided through this medicine.